Bassem Habr

Dr. Bassem Habr

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MRMarc Raad
Marc Raad
MHMarc Abou Haidar
Marc Abou Haidar
RIRacha Ibrahim
Racha Ibrahim
RRRouba Rahal
Rouba Rahal
JJJocelyne Abou Jaoude
Jocelyne Abou Jaoude
MRMoussa Riachy
Moussa Riachy
Stenotrophomonas maltophilia, an environmental aerobic non-fermentative Gram-negative bacilli, has gained attention in many nosocomial outbreaks. COVID-19 patients in intensive care unit have extended hospital stay and are severely immunosuppressed. This study aimed to determine the prevalence and risk factors of S.maltophilia pneumonia in critical COVID-19 patients. A total of 123 COVID-19 patients in ICU admitted between March 2020 and March 2021 were identified from the authors’ institutional database and assessed for nosocomial pneumonia. Demographic data and factors predisposing to S. maltophilia pneumonia were collected and analyzed. The mean age was 66 ± 13 years and 74% were males. Median APACHE and SOFA scores were 13 (IQR = 8–19) and 4 (3–6), respectively. The Median NEWS2 score was 6 (Q1 = 5; Q3 = 8). The Median ICU stay was 12 (Q1 = 7; Q3 = 22) days. S. maltophilia was found in 16.3% of pneumonia patients, leading to a lengthier hospital stay (34 vs. 20 days; p < 0.001). Risk factors for S. maltophilia pneumonia included previous treatment with meropenem (p < 0.01), thrombopenia (p = 0.034), endotracheal intubation (p < 0.001), foley catheter (p = 0.009) and central venous catheter insertion (p = 0.016). S.maltophilia nosocomial pneumonia is frequent in critical COVID-19 patients. Many significant risk factors should be addressed to reduce its prevalence and negative impact on outcomes.

14 November 2019 in Transfusion
Verified
Journal Article
Closed access
EBElodie Baron
Elodie Baron
JCJulien Charpentier
Julien Charpentier
AFAnne François
Anne François
HAHabib Ben Hadj Amor
Habib Ben Hadj Amor
BHBassem Habr
Bassem Habr
FPFrédéric Pène
Frédéric Pène

27 November 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Rouba KeyrouzRouba Keyrouz
Rouba Keyrouz
BHBassem Habr
Bassem Habr
Marianne ANTAR SOUTOUMarianne ANTAR SOUTOU
Marianne ANTAR SOUTOU
SISirine Abou Ismail
Sirine Abou Ismail
MAMarianne Abifadel
Marianne Abifadel
EHElie Haddad
Elie Haddad
The epidemiology of respiratory viruses shifted considerably following the COVID-19 pandemic and the subsequent rollback of non-pharmaceutical interventions (NPIs). The initial global containment strategies implemented during the SARS-CoV-2 outbreak profoundly altered viral transmission dynamics and circulation patterns. As the World Health Organization (WHO) declared COVID-19 no longer a public health emergency in May 2023, viral circulation began reverting to pre-pandemic trends. This retrospective observational study examined the evolving epidemiological patterns of respiratory infections during and after the lifting of NPI, assessing associated clinical manifestations and their relationship with patient-specific risk factors. Data were collected from 307 patients tested between October 2021 and December 2024 using a respiratory multiplex PCR at the Rodolphe Mérieux Laboratory in Lebanon. Results revealed a reemergence of pre-pandemic seasonal trends for most viruses. Rhinovirus remained the most prevalent pathogen, likely due to the absence of a vaccine. Respiratory syncytial virus (RSV) and Influenza A resumed their characteristic winter peaks, while human metapneumovirus (HMPV) showed no co-infections, suggesting viral interference. The persistence of Influenza A and SARS-CoV-2 appeared influenced by vaccine coverage, viral mutations, and environmental factors. Multiplex PCR testing proved to be a valuable yet costly tool for both diagnosis and epidemiological surveillance. Overall, this study highlights the importance of continued viral monitoring in the post-NPI period, reflecting both the effectiveness of NPIs in limiting viral spread and the importance of ensuring wider access to advanced diagnostic methods.

25 February 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
EHElie Haddad
Elie Haddad
BHBassem Habr
Bassem Habr
HNHussein Nassereddine
Hussein Nassereddine
NFNassim Fares
Nassim Fares
Background: Extended-spectrum β-lactamase (ESBL)–producing Escherichia coli represent an increasing therapeutic challenge. While ertapenem (ERP) is commonly used as first-line therapy, amoxicillin–clavulanic acid (AMC) achieves therapeutic concentrations in serum and ascitic fluid and may offer a narrower-spectrum alternative. This exploratory preclinical study evaluated whether AMC produces effects comparable to ERP in a rat model of ESBL E. coli peritonitis. Methods: Thirty-three male rats were allocated to four groups: untreated E. coli, AMC, ERP, and sham controls. Peritonitis was induced by intraperitoneal injection of an ESBL-producing E. coli strain. The primary outcome was peritoneal bacterial culture positivity. Secondary outcomes included plasma inflammatory cytokines (CRP, PCT, TNF-α, IL-1β, IL-6), proteomic signaling markers, and histopathological inflammation scores in the peritoneum, spleen, and lungs. Results: One death occurred in the untreated group. Both AMC and ERP were associated with lower peritoneal culture positivity compared with untreated animals, with ERP achieving statistical significance and AMC showing a similar downward trend. Inflammatory cytokines and proteomic markers demonstrated comparable reductions in both treated groups. Histopathology showed reduced inflammatory scores, with AMC exhibiting the lowest peritoneal inflammation. Lung involvement was observed in 7/10 untreated rats versus 5/10 AMC- and ERP-treated rats; these differences were not statistically significant, reflecting the limited sample size. Conclusions: AMC and ERP produced broadly comparable effects on microbiological, biochemical, and inflammatory parameters in ESBL E. coli peritonitis. These findings suggest that AMC may merit further investigation as a potential narrower-spectrum option, though definitive comparisons require larger, adequately powered studies.